GUMDROP : JHMI J11151 A Phase 3, randomized, double-blind, controlled trial of cabozantinib -XL184- vs. mitoxantrone plus prednisone in men with previously treated symptomatic CRPC

Created by Channing Paller, last modified on Apr 14, 2012

Description:

CRPC with bone mets and doumented pain from bone mets on opioid narcotic regimen; mush have prior docetaxel and either abiraterone or MDV3100; NO prior cabozantinib or mitoxantrone; NO liver mets or known brain mets

Link:

http://clinicaltrials.gov/ct2/show/NCT01522443

Site:

Johns Hopkins Hospital

Principal Investigator:

Emmanuel Antonarakis, M.D.